Skip to main content

Table 8 Correlation between the miPSMA expression score and the other obtained metabolic parameters

From: [68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study

T2/T1-quotient (Q) of miPSMA score

Q SUVmax

Q LN_SUVmax

Q SUVmean

Q LN_SUVmean

Q PSMA-TV

Q TL-PSMA

Q LN-TL-PSMA

Q PSA

T2 PSA

All lesions

         

Correlation coefficient

0.970

0.969

0.970

0.969

0.828

0.903

0.896

0.185

0.472

p value

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

0.057

 < 0.001

Primary tumor

         

Correlation coefficient

0.874

0.893

0.866

0.885

0.505

0.669

0.666

0.257

0.162

p value

 < 0.001

 < 0.001

 < 0.001

 < 0.001

0.012

 < 0.001

 < 0.001

0.226

0.449

Lymph node metastases

         

Correlation coefficient

0.968

0.976

0.967

0.975

0.886

0.933

0.931

0.105

0.484

p value

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

0.442

 < 0.001

Bone metastases

         

Correlation coefficient

0.945

0.951

0.945

0.951

0.873

0.917

0.917

0.132

0.547

p value

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

 < 0.001

0.510

0.003

  1. Q, quotient of T2/T1; LN, liver normalization [value divided by hepatic SUVmean]. Significant correclation coefficents and their exact p-value are marked bold